Herbalife (HLF) is drawing attention after outlining an updated focus on growth, margin expansion, product development, and debt reduction, along with plans for a high profile fireside chat at the Barclays Global Consumer Conference.

Recent attention around Herbalife's refreshed growth plan and upcoming Barclays conference appearance comes against a mixed backdrop, with the share price around $12.35 and a 1 year total shareholder return of 34.68%, yet a 5 year total shareholder return that has fallen 76.24%, showing shorter term momentum improving while longer term returns remain weak.

Compare Herbalife's refreshed plan with other consumer and wellness stocks that show improving returns and focused execution by scanning the hand picked 46 high quality undervalued stocks list.

After a sharp 1 year rebound but heavy 5 year value erosion, Herbalife now sits at a crossroads. Does the current price still leave enough upside to justify the business risks investors are taking on?

Most Popular Narrative: 27.4% Undervalued

The most followed narrative on Herbalife pegs fair value at $17.00, above the recent $12.35 share price, and builds a case around earnings recovery and margin improvement.

The analysts have a consensus price target of $17.0 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $5.6 billion, earnings will come to $506.4 million, and it would be trading on a PE ratio of 5.0x, assuming you use a discount rate of 10.4%.

The core of this Herbalife narrative is a sizeable earnings ramp, firmer margins, and a much lower profit multiple than many peers. It examines which assumptions would need to hold together for that fair value to make sense, and how sensitive the outcome is to small changes in growth or profitability.

Result: Fair Value of $17.00 (UNDERVALUED)

However, Herbalife still faces meaningful risks, including tighter global regulation of multi level marketing and supplement claims, as well as persistently weak volumes in several key regions.

Next Steps

The mixed tone of this Herbalife review means you are weighing both concern and optimism. Move quickly and stress test that view against the 3 key rewards and 4 important warning signs.

Looking for more investment ideas beyond Herbalife?

If Herbalife has sharpened your focus, do not stop here. Use the Simply Wall St screener to surface other opportunities that might suit your approach.

• Target resilient balance sheets by checking the list of solid balance sheet and fundamentals (50 results) that highlights companies with stronger financial footing.
• Hunt for potentially mispriced opportunities by reviewing the curated 46 high quality undervalued stocks that filters for quality alongside value.
• Prioritise stability and ongoing income potential by scanning the 12 dividend fortresses focused on companies with higher yielding payouts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.